I've got good medical news for you,

@cure.qunewe

14.6K followers · usually 877 views a post

Views

32.4K

Likes

1.5K

Comments

79

Shares

604

Promoted product

Lorelatinib

Why it worked

The video highlights a significant breakthrough in cancer treatment with dramatic statistics (60% vs 8% success rate), making it highly shareable and attention-grabbing for a broad audience interested in health and medical news.

Summary

A new lung cancer drug called Lorelatinib has shown remarkable results in clinical trials, with over 60% of patients with advanced disease experiencing no progression after five years. This is a significant improvement compared to the standard treatment, which has an 8% success rate.

Free account

Transcript, structure and on-screen text

5 beats, a 240-word transcript and 18 lines of on-screen text — the parts you need to write your own version.

Create a free account to see the full breakdown

Original caption

Exciting news in lung cancer treatment! A new drug, Lorelatinib, shows 60% of patients with advanced lung cancer experience no progression after 5 years. This promising ALK inhibitor could change lives! What do you think about these results? #lungcancer #cancertreatment #medtech #Science #fyp #foryou #cancer #tiktok